| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |